Global injectable drug delivery market expected to generate around USD 932.3 billion by 2025, at a CAGR of 11.2% between 2019 and 2025. The global injectable drug delivery market is anticipated to grow at a considerable rate over the forecast time period, owing to the growing prevalence of various chronic diseases, such as cancer, heart diseases, diabetes etc.
The report covers a forecast and an analysis of the injectable drug delivery market on a global and regional level. The study provides historical data for 2017 and 2018 along with a forecast from 2019 to 2025 based revenue (USD Billion). The study includes drivers and restraints of the injectable drug delivery market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the injectable drug delivery market on a global level.
In order to give the users of this report a comprehensive view of the injectable drug delivery market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new application launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.
The study provides a decisive view of the injectable drug delivery market based on type, application, end-user, and region. By type, the global injectable drugs market includes formulation and devices. The formulation segment is sub-segmented into conventional drug delivery (suspensions, solutions, lyophilized formulations, and emulsions), novel drug delivery (long-acting injection formulation, colloidal dispersions, and microparticles), and others. The devices segment includes conventional injection devices and self-injection devices. The self-injection devices segment is further classified into needle-free injectors (NFI), pen injectors, wearable injectors, auto-injectors, and others. The conventional injection devices are segmented into prefilled syringes, fillable syringes, and others. By application, the global injectable drug delivery market is segmented into autoimmune diseases, oncology disorders, hormonal disorders, orphan diseases, and others. By end-user, this global market includes home care, hospital, ambulatory care, physician offices or clinics, and others. By geography, the global injectable drug delivery market includes Latin America, North America, Asia Pacific, Europe, and the Middle East and Africa with its further division into major countries, such as the U.S., Rest of North America, UK, Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa, and Rest of the Middle East and Africa.
Some key players of the global injectable drug delivery market are Baxter International, Nova Nordisk A/S, Becton Dickinson, Sanofi, Pfizer, InjexPharma GmbH, Terumo Corporation, Unilife Corporation, Gerresheimer AG, Vetter Pharma-Fertigung GmbH & Co. KG., Schott AG, and Eli Lily & Company.
Report Scope:
Report Attribute | Details |
---|---|
Base Year | 2020 |
Historic Years | 2016 - 2020 |
Forecast Years | 2021 - 2028 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2021 to 2028 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Number of Companies Covered | 10 companies with scope for including additional 15 companies upon request |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. |
This report segments the global injectable drug delivery market into:
Global Injectable Drug Delivery Market: Type Analysis
Global Injectable Drug Delivery Market: Application Analysis
Global Injectable Drug Delivery Market: End-User Analysis
Global Injectable Drug Delivery Market: Regional Analysis
List of Figures
1. Market research process
2. Market research methodology
3. Global Injectable Drug Delivery Market revenue, 2017–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Injectable Drug Delivery Market attractiveness analysis, by type
6. Injectable Drug Delivery Market attractiveness analysis, by application
7. Injectable Drug Delivery Market attractiveness analysis, by end-user
8. Injectable Drug Delivery Market: market attractiveness analysis, by region
9. Company market share analysis, 2017
10. Global Injectable Drug Delivery Market revenue share by type, 2018 and 2025
11. Global Injectable Drug Delivery Market revenue share by Formulation, 2018 and 2025
12. Global Injectable Drug Delivery Market revenue share by Devices, 2018 and 2025
13. Global Injectable Drug Delivery Market revenue share by application, 2018 and 2025
14. Global Injectable Drug Delivery Market revenue share by Autoimmune Diseases, 2018 and 2025
15. Global Injectable Drug Delivery Market revenue share by Oncology Disorders, 2018 and 2025
16. Global Injectable Drug Delivery Market revenue share by Hormonal Disorders, 2018 and 2025
17. Global Injectable Drug Delivery Market revenue share by Orphan Diseases, 2018 and 2025
18. Global Injectable Drug Delivery Market revenue share by Others, 2018 and 2025
19. Global Injectable Drug Delivery Market revenue share by End-User, 2018 and 2025
20. Global Injectable Drug Delivery Market revenue share by Home Care, 2018 and 2025
21. Global Injectable Drug Delivery Market revenue share by Hospital, 2018 and 2025
22. Global Injectable Drug Delivery Market revenue share by Ambulatory Care, 2018 and 2025
23. Global Injectable Drug Delivery Market revenue share by Physicians office or clinics, 2018 and 2025
24. Global Injectable Drug Delivery Market revenue share by Others, 2018 and 2025
List of Tables
1. Injectable Drug Delivery Market: market snapshot
2. Drivers of Global Injectable Drug Delivery Market: impact analysis
3. Restraints of Global Injectable Drug Delivery Market: impact analysis
4. North America Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
5. North America Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
6. North America Injectable Drug Delivery Market revenue, by end-user, 2017–2025 (USD Billion)
7. The U.S. Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
8. The U.S. Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
9. The U.S. Injectable Drug Delivery Market revenue, by end-user, 2017–2025 (USD Billion)
10. Rest of North America Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
11. Rest of North America Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
12. Rest of North America Injectable Drug Delivery Market revenue, by end-user, 2017–2025 (USD Billion)
13. Europe Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
14. Europe Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
15. Europe Injectable Drug Delivery Market revenue, by end-user, 2017–2025 (USD Billion)
16. U.K. Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
17. U.K. Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
18. U.K. Injectable Drug Delivery Market revenue, by end-user, 2017–2025 (USD Billion)
19. Germany Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
20. Germany Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
21. Germany Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
22. France Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
23. France Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
24. Italy Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
25. Italy Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
26. Italy Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
27. Spain Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
28. Spain Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
29. Rest of Europe Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
30. Rest of Europe Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
31. Rest of Europe Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
32. Asia Pacific Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
33. Asia Pacific Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
34. Asia Pacific Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
35. China Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
36. China Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
37. China Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
38. Japan Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
39. Japan Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
40. Japan Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
41. India Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
42. India Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
43. India Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
44. Southeast Asia Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
45. Southeast Asia Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
46. Southeast Asia Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
47. Rest of Asia Pacific Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
48. Rest of Asia Pacific Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
49. Rest of Asia Pacific Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
50. Latin America Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
51. Latin America Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
52. Latin America Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
53. Brazil Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
54. Brazil Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
55. Brazil Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
56. Rest of Latin America Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
57. Rest of Latin America Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
58. Rest of Latin America Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
59. The Middle East and Africa Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
60. The Middle East and Africa Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
61. The Middle East and Africa Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
62. GCC Countries Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
63. GCC Countries Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
64. GCC Countries Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
65. South Africa Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
66. South Africa Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
67. South Africa Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
68. Rest of the Middle East and Africa Injectable Drug Delivery Market revenue, by type, 2017–2025 (USD Billion)
69. Rest of the Middle East and Africa Injectable Drug Delivery Market revenue, by application, 2017–2025 (USD Billion)
70. Rest of the Middle East and Africa Injectable Drug Delivery Market revenue, by End-User, 2017–2025 (USD Billion)
Injecting of medicines or drugs directly into patients’ blood via a delivery device is called injectable drug delivery. Some pharmaceutical agents, predominant peptides, proteins, etc. can be administered via injectable routes. The parenteral administration route is one of the most common and efficient drug delivery types. Injectable drug delivery ensures a quick passage of a drug into the body by avoiding first pass metabolism. This drug delivery system also helps in administering drugs in comatose patients. For various medical conditions, such as cystic fibrosis, hormonal imbalance, autoimmune diseases, Wilson’s disease, hepatitis C, ribose-5-phosphate isomerase, and hemophilia, the injectable drug delivery system is preferred mostly.
The global injectable drug delivery market is anticipated to grow at a considerable rate over the forecast time period, owing to the growing prevalence of various chronic diseases, such as cancer, heart diseases, diabetes etc., and technological innovations related to advanced device development in injectable drug delivery systems.
The global injectable drug delivery market is fragmented into type, application, and end-user. By type, the global injectable drugs market includes formulation and devices. The formulation segment is sub-segmented into conventional drug delivery (suspensions, solutions, lyophilized formulations, and emulsions), novel drug delivery (long-acting injection formulation, colloidal dispersions, and microparticles), and others. The devices segment includes conventional injection devices and self-injection devices. The self-injection devices segment is further classified into needle-free injectors (NFI), pen injectors, wearable injectors, auto-injectors, and others. The conventional injection devices are segmented into prefilled syringes, fillable syringes, and others. By application, the global injectable drug delivery market is segmented into autoimmune diseases, oncology disorders, hormonal disorders, orphan diseases, and others. By end-user, this global market includes home care, hospital, ambulatory care, physician offices or clinics, and others.
By geography, the global injectable drug delivery market includes Latin America, North America, Asia Pacific, Europe, and the Middle East and Africa. North America held the largest share of the global market in 2017 and is anticipated to remain dominant over the forecast time period as well. In terms of growth rate, the Asia Pacific region is expected to register the highest CAGR over the estimated time period. India and China held the largest shares of the Asia Pacific injectable drug delivery market in 2018.
Some key players of the global injectable drug delivery market are Baxter International, Nova Nordisk A/S, Becton Dickinson, Sanofi, Pfizer, InjexPharma GmbH, Terumo Corporation, Unilife Corporation, Gerresheimer AG, Vetter Pharma-Fertigung GmbH & Co. KG., Schott AG, and Eli Lily & Company.
Request the coronavirus impact analysis across industries and markets
Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No 020-46277770
US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed